A graduate of the University of North Carolina Eshelman School of Pharmacy, Sherif El-Refai conducts research on lung cancer at the University of Kentucky College of Pharmacy. Sherif El-Refai concurrently serves as an oncology pharmacist at the University of Kentucky (UK) Markey Cancer Center, which has received recognition from the National Cancer Institute (NCI).
The UK Markey Cancer Center stands out as the only cancer center in the state of Kentucky and one of just 69 centers in the country to receive the coveted NCI designation. The honor recognizes cancer centers that have demonstrated excellence in laboratory and clinical research as well as behavioral and population-based studies.
NCI-designated cancer centers have access to exclusive clinical trials and new drugs and treatments. The designation also provides the Markey Cancer Center with an additional $2 million in funding per year and the opportunity to recruit some of the top medical students and faculty from around the world. The Markey Cancer Center also can collaborate on cancer research with other NCI-designated centers throughout the country.